Igue, Raouf <br/><br/>
Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.  [electronic resource] 

 -  Progress in neuro-psychopharmacology & biological psychiatry  Aug 2011 
 - 1695-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-4216 
<br/><br/><label>Standard No.: </label>10.1016/j.pnpbp.2011.05.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Affective Symptoms--diagnosis<br/>Antipsychotic Agents--pharmacology<br/>Comorbidity<br/>Cytokines--blood<br/>Dibenzothiazepines--pharmacology<br/>Female<br/>Humans<br/>Interleukin-6--blood<br/>Male<br/>Psychiatric Status Rating Scales<br/>Quetiapine Fumarate<br/>Receptors, Interleukin-1--antagonists & inhibitors<br/>Receptors, Interleukin-2--blood<br/>Schizophrenia--diagnosis<br/>Substance-Related Disorders--drug therapy<br/>Young Adult